Johnson & Johnson - Company Profile

Powered by

All the data and insights you need on Johnson & Johnson in one report.

  • Save hours of research time and resources with
    our up-to-date Johnson & Johnson Strategy Report

  • Understand Johnson & Johnson position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products and medical devices. The company conducts business through its operating companies. It provides pharmaceuticals for immune disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; and medical devices for use in cardiovascular, orthopaedic, neurovascular care, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, healthcare professionals and hospitals. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US) and Latin America. J&J is headquartered in New Brunswick, New Jersey, the US.

Gain a 360-degree view of Johnson & Johnson and make more informed decisions for your business Gain a 360-degree view of Johnson & Johnson and make more informed decisions for your business Find out more
Headquarters United States of America

Address One Johnson & Johnson Plaza, New Brunswick, New Jersey, 08933


Telephone 1 732 5242455

No of Employees 131,900

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange JNJ (NYSE)

Revenue (2023) $85.2B

EPS XYZ

Market Cap* $381.0B

Net Profit Margin (2023) XYZ 84.0%

   

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Johnson & Johnson premium industry data and analytics

4,300+

Clinical Trials

Determine Johnson & Johnson go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,600+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Johnson & Johnson’s relevant decision makers and contact details.

1,500+

Catalyst Calendar

Proactively evaluate Johnson & Johnson’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

760+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

670+

Pipeline Drugs

Identify which of Johnson & Johnson’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

330+

Marketed Drugs

Understand Johnson & Johnson’s commercialized product portfolio to stay one step ahead of the market.

100+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

50+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Johnson & Johnson and assess market opportunity for new entrants with patient population 8-year forecasts.

2

Investigators

Review investigator profiles and find information on trial contacts across Johnson & Johnson, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

9

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Johnson & Johnson (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Johnson & Johnson’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Pharmaceutical -
Immunology: Johnson’s
Rheumatoid Arthritis Listerine
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Johnson & Johnson portfolio and identify potential areas for collaboration Understand Johnson & Johnson portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Acquisitions/Mergers/Takeovers In March, the company acquired Ambrx Biopharma, Inc, a clinical-stage biopharmaceutical company.
2024 Regulatory Approval In March, the company secured approval from the U.S. Food and Drug Administration for RYBREVANT (amivantamab-vmjw) in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients.
2024 Contracts/Agreements In February, the company collaborated with Pharmacyclics to secure approval from the U.S. Food and Drug Administration for IMBRUVICA (ibrutinib) with an oral suspension formulation for adult patients in the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), Waldenström’s macroglobulinemia (WM) and chronic graft versus host disease (cGVHD).
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Johnson & Johnson F. Hoffmann-La Roche Ltd Merck & Co Inc Pfizer Inc Sanofi
Headquarters United States of America Switzerland United States of America United States of America France
City New Brunswick Basel Kenilworth New York Paris
State/Province New Jersey - New Jersey New York Ile-de-France
No. of Employees 131,900 103,605 72,000 88,000 87,994
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Joaquin Duato Chief Executive Officer; Chairman Executive Board 2023 61
Joseph J. Wolk Executive Vice President; Chief Financial Officer Senior Management 2018 57
James Swanson Chief Information Officer; Executive Vice President Senior Management 2022 58
Kathryn E. Wengel Executive Vice President; Chief Technical Operations & Risk Officer Senior Management 2023 58
William N. Hait, M.D., Ph. D. Executive Vice President; Chief External Innovation and Medical Safety Officer Senior Management 2022 74
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Johnson & Johnson key executives to enhance your sales strategy Gain insight into Johnson & Johnson key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward